An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Bowery Clinic, which offers doctor-supervised peptide treatments, has announced it’s adding a deeper focus on a synthetic peptide called selank to its program. The clinic is promoting selank as something that’s been studied for helping with stress, anxiety, and thinking (cognitive) support. The announcement is about expanding availability and providing more information to patients who might be curious or interested. Selank is a lab-made short protein fragment (a peptide) that was originally developed in Russia. Think of peptides as tiny, simplified versions of the bigger proteins our bodies make; they can be designed to mimic or tweak certain signals in the brain or body. Selank is not a hormone like insulin; it’s more like a small messaging molecule that researchers believe can influence stress responses and certain brain chemicals involved in mood and memory. What the research shows so far is limited and mixed. Most studies on selank come from a handful of research groups and often involve animal experiments or small human trials, usually in Russia and some nearby countries. Those studies suggest selank might reduce anxiety-like behavior and have short-term effects on attention and memory, but sample sizes are small and methods vary. There’s no large, international clinical trial proving strong, reliable benefits in broad populations. So the evidence hints that it could help some people, but it’s far from definitive or broadly accepted in mainstream medicine. Why this matters is practical: people dealing with anxiety, stress, or mild cognitive complaints are often looking for alternatives when standard treatments don’t work well or have unwanted side effects. A physician-guided program can offer medical oversight, dosing advice, and monitoring, which is safer than self-experimentation. Patients interested in new or niche treatments might see this as another option to discuss with their doctor, especially if they’ve already explored first-line therapies. There are important caveats. Selank is not approved by major regulators like the U.S. FDA as a standard treatment for anxiety or cognitive disorders. Long-term safety and side effects haven’t been well characterized in large, rigorous studies. Possible issues with any peptide therapy include injection-site reactions or unexpected interactions with other medications. People who are pregnant, breastfeeding, or on multiple psychiatric medications should be especially cautious and consult a physician. Also, because much of the research is limited and region-specific, claims of broad effectiveness should be viewed skeptically. Bottom line: Bowery Clinic is offering more access and information about selank, a synthetic peptide with early, limited evidence for stress and cognitive effects — it’s an interesting option under medical supervision, but not a proven or widely approved therapy.
Source: Rutland Herald